Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223471512> ?p ?o ?g. }
- W4223471512 endingPage "842" @default.
- W4223471512 startingPage "842" @default.
- W4223471512 abstract "The dosage regimen of vancomycin, teicoplanin and daptomycin remains controversial for critically ill patients undergoing continuous renal replacement therapy (CRRT). Monte Carlo simulation was applied to identify the optimal regimens of antimicrobial agents in patients with methicillin-resistant Staphylococcus aureus (MRSA) infections based on the mechanisms of different CRRT modalities on drug clearance. The optimal vancomycin dosage for patients received a CRRT doses ≤ 30 mL/kg/h was 20 mg/kg loading dose followed by 500 mg every 8 h, while 1 g every 12 h was appropriate when 35 mL/kg/h was prescribed. The optimal teicoplanin dosage under a CRRT dose ≤ 25 mL/kg/h was four loading doses of 10 mg/kg every 12 h followed by 10 mg/kg every 48 h, 8 mg/kg every 24 h and 6 mg/kg every 24 h for continuous veno-venous hemofiltration, continuous veno-venous hemodialysis and continuous veno-venous hemodiafiltration, respectively. When the CRRT dose increased to 30-35 mL/kg/h, the teicoplanin dosage should be increased by 30%. The recommended regimen for daptomycin was 6-8 mg/kg every 24 h under a CRRT dose ≤ 25 mL/kg/h, while 8-10 mg/kg every 24 h was optimal under 30-35 mg/kg/h. The CRRT dose has an impact on probability of target attainment and CRRT modality only influences teicoplanin." @default.
- W4223471512 created "2022-04-15" @default.
- W4223471512 creator A5002441340 @default.
- W4223471512 creator A5005744006 @default.
- W4223471512 creator A5007746021 @default.
- W4223471512 creator A5010738468 @default.
- W4223471512 creator A5013604776 @default.
- W4223471512 creator A5013955645 @default.
- W4223471512 creator A5018095727 @default.
- W4223471512 creator A5040961134 @default.
- W4223471512 creator A5047170684 @default.
- W4223471512 creator A5075134934 @default.
- W4223471512 creator A5079975949 @default.
- W4223471512 date "2022-04-11" @default.
- W4223471512 modified "2023-09-25" @default.
- W4223471512 title "Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy" @default.
- W4223471512 cites W125250342 @default.
- W4223471512 cites W1959537530 @default.
- W4223471512 cites W1973677540 @default.
- W4223471512 cites W1977876649 @default.
- W4223471512 cites W1979060371 @default.
- W4223471512 cites W1979827848 @default.
- W4223471512 cites W1982668074 @default.
- W4223471512 cites W1983960319 @default.
- W4223471512 cites W1984214310 @default.
- W4223471512 cites W1997261364 @default.
- W4223471512 cites W2014256079 @default.
- W4223471512 cites W2017487363 @default.
- W4223471512 cites W2020311766 @default.
- W4223471512 cites W2039915339 @default.
- W4223471512 cites W2045264488 @default.
- W4223471512 cites W2052264066 @default.
- W4223471512 cites W2057910559 @default.
- W4223471512 cites W2072325464 @default.
- W4223471512 cites W2091061282 @default.
- W4223471512 cites W2100961719 @default.
- W4223471512 cites W2106444474 @default.
- W4223471512 cites W2108433768 @default.
- W4223471512 cites W2115005239 @default.
- W4223471512 cites W2116089057 @default.
- W4223471512 cites W2117958746 @default.
- W4223471512 cites W2119313009 @default.
- W4223471512 cites W2124537897 @default.
- W4223471512 cites W2130937463 @default.
- W4223471512 cites W2131370687 @default.
- W4223471512 cites W2131957214 @default.
- W4223471512 cites W2134827823 @default.
- W4223471512 cites W2137092327 @default.
- W4223471512 cites W2141559993 @default.
- W4223471512 cites W2147240880 @default.
- W4223471512 cites W2153572990 @default.
- W4223471512 cites W2523096729 @default.
- W4223471512 cites W2889630471 @default.
- W4223471512 cites W2890186512 @default.
- W4223471512 cites W2894202568 @default.
- W4223471512 cites W2911919065 @default.
- W4223471512 cites W2914543184 @default.
- W4223471512 cites W2961873923 @default.
- W4223471512 cites W2987587756 @default.
- W4223471512 cites W3008204453 @default.
- W4223471512 cites W3012868903 @default.
- W4223471512 cites W3022327571 @default.
- W4223471512 cites W3032253244 @default.
- W4223471512 cites W3214353565 @default.
- W4223471512 cites W4211003757 @default.
- W4223471512 doi "https://doi.org/10.3390/pharmaceutics14040842" @default.
- W4223471512 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35456676" @default.
- W4223471512 hasPublicationYear "2022" @default.
- W4223471512 type Work @default.
- W4223471512 citedByCount "4" @default.
- W4223471512 countsByYear W42234715122022 @default.
- W4223471512 countsByYear W42234715122023 @default.
- W4223471512 crossrefType "journal-article" @default.
- W4223471512 hasAuthorship W4223471512A5002441340 @default.
- W4223471512 hasAuthorship W4223471512A5005744006 @default.
- W4223471512 hasAuthorship W4223471512A5007746021 @default.
- W4223471512 hasAuthorship W4223471512A5010738468 @default.
- W4223471512 hasAuthorship W4223471512A5013604776 @default.
- W4223471512 hasAuthorship W4223471512A5013955645 @default.
- W4223471512 hasAuthorship W4223471512A5018095727 @default.
- W4223471512 hasAuthorship W4223471512A5040961134 @default.
- W4223471512 hasAuthorship W4223471512A5047170684 @default.
- W4223471512 hasAuthorship W4223471512A5075134934 @default.
- W4223471512 hasAuthorship W4223471512A5079975949 @default.
- W4223471512 hasBestOaLocation W42234715121 @default.
- W4223471512 hasConcept C126322002 @default.
- W4223471512 hasConcept C141071460 @default.
- W4223471512 hasConcept C2776703206 @default.
- W4223471512 hasConcept C2777288759 @default.
- W4223471512 hasConcept C2778063415 @default.
- W4223471512 hasConcept C2778651397 @default.
- W4223471512 hasConcept C2778865887 @default.
- W4223471512 hasConcept C2778980435 @default.
- W4223471512 hasConcept C2779489039 @default.
- W4223471512 hasConcept C2779541074 @default.
- W4223471512 hasConcept C2781413609 @default.
- W4223471512 hasConcept C2991859549 @default.
- W4223471512 hasConcept C35294091 @default.